|
TMTC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93299998230145E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.76599965154389E-10 |
| Normal-vs-Stage2 |
1.921810E-02 |
| Normal-vs-Stage3 |
1.004450E-03 |
| Normal-vs-Stage4 |
1.594160E-02 |
| Stage1-vs-Stage2 |
5.056200E-01 |
| Stage1-vs-Stage3 |
6.446000E-01 |
| Stage1-vs-Stage4 |
8.214800E-01 |
| Stage2-vs-Stage3 |
7.924400E-01 |
| Stage2-vs-Stage4 |
7.621800E-01 |
| Stage3-vs-Stage4 |
9.105000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.25579996296455E-09 |
| Normal-vs-AfricanAmerican |
1.40129999826044E-08 |
| Normal-vs-Asian |
4.794200E-04 |
| Caucasian-vs-AfricanAmerican |
4.774400E-01 |
| Caucasian-vs-Asian |
5.333200E-01 |
| AfricanAmerican-vs-Asian |
6.998400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96080041092728E-10 |
| Normal-vs-Female |
2.564800E-04 |
| Male-vs-Female |
4.559900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.34650000038761E-08 |
| Normal-vs-Extreme_Weight |
1.40010225635478E-11 |
| Normal-vs-Obese |
4.54719999998243E-06 |
| Normal-vs-Extreme_Obese |
3.799000E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.981400E-01 |
| Normal_Weight-vs-Obese |
3.587400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.046600E-01 |
| Extreme_Weight-vs-Obese |
5.831800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.299600E-01 |
| Obese-vs-Extreme_Obese |
7.799600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.14120001915819E-09 |
| Normal-vs-Age(41-60Yrs) |
2.26739999997783E-07 |
| Normal-vs-Age(61-80Yrs) |
7.83759945832685E-10 |
| Normal-vs-Age(81-100Yrs) |
2.91230000004639E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.580400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.104220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.580800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.403830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.969700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.261600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.98410177176811E-11 |
| Normal-VS-Type2 PRCC |
1.00680000003628E-06 |
| Normal-VS-KIRP CIMP |
1.81380000019438E-07 |
| Normal-VS-Unclassified PRCC |
1.275510E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.496200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.559500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.559390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.335800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.602000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.051800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.22599996821293E-09 |
| Normal-vs-N1 |
3.461800E-02 |
| Normal-vs-N2 |
1.563690E-04 |
| N0-vs-N1 |
1.074050E-01 |
| N0-vs-N2 |
5.584000E-01 |
| N1-vs-N2 |
2.909200E-01 |
|
|
